Garrido Alejandra del Pilar Gallardo, Cruz Ruy Jorge, Poli de Figueiredo Luiz Francisco, Rocha e Silva Maurício
Research Division, Heart Institute (InCor), University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Crit Care. 2006;10(2):R62. doi: 10.1186/cc4901.
We conducted the present study to examine the effects of hypertonic saline solution (7.5%) on cardiovascular function and splanchnic perfusion in experimental sepsis.
Anesthetized and mechanically ventilated mongrel dogs received an intravenous infusion of live Escherichia coli over 30 minutes. After 30 minutes, they were randomized to receive lactated Ringer's solution 32 ml/kg (LR; n = 7) over 30 minutes or 7.5% hypertonic saline solution 4 ml/kg (HS; n = 8) over 5 minutes. They were observed without additional interventions for 120 minutes. Cardiac output (CO), mean arterial pressure (MAP), portal and renal blood flow (PBF and RBF, respectively), gastric partial pressure of CO2 (pCO2; gas tonometry), blood gases and lactate levels were assessed.
E. coli infusion promoted significant reductions in CO, MAP, PBF and RBF (approximately 45%, 12%, 45% and 25%, respectively) accompanied by an increase in lactate levels and systemic and mesenteric oxygen extraction (sO2ER and mO2ER). Widening of venous-arterial (approximately 15 mmHg), portal-arterial (approximately 18 mmHg) and gastric mucosal-arterial (approximately 55 mmHg) pCO2 gradients were also observed. LR and HS infusion transiently improved systemic and regional blood flow. However, HS infusion was associated with a significant and sustained reduction of systemic (18 +/- 2.6 versus 38 +/- 5.9%) and mesenteric oxygen extraction (18.5 +/- 1.9 versus 36.5 +/- 5.4%), without worsening other perfusional markers.
A large volume of LR or a small volume of HS promoted similar transient hemodynamic benefits in this sepsis model. However, a single bolus of HS did promote sustained reduction of systemic and mesenteric oxygen extraction, suggesting that hypertonic saline solution could be used as a salutary intervention during fluid resuscitation in septic patients.
我们开展本研究以检测高渗盐溶液(7.5%)对实验性脓毒症中心血管功能和内脏灌注的影响。
对麻醉并机械通气的杂种犬在30分钟内静脉输注活的大肠杆菌。30分钟后,将它们随机分为两组,一组在30分钟内输注32 ml/kg乳酸林格液(LR;n = 7),另一组在5分钟内输注4 ml/kg 7.5%高渗盐溶液(HS;n = 8)。在无额外干预的情况下观察120分钟。评估心输出量(CO)、平均动脉压(MAP)、门静脉和肾血流量(分别为PBF和RBF)、胃二氧化碳分压(pCO2;气体张力测定法)、血气和乳酸水平。
输注大肠杆菌促使CO、MAP、PBF和RBF显著降低(分别约为45%、12%、45%和25%),同时乳酸水平以及全身和肠系膜氧摄取(sO2ER和mO2ER)增加,并观察到静脉 - 动脉(约15 mmHg)、门静脉 - 动脉(约18 mmHg)和胃黏膜 - 动脉(约55 mmHg)pCO2梯度增宽。输注LR和HS可短暂改善全身和局部血流。然而,输注HS与全身(18±2.6对38±5.9%)和肠系膜氧摄取的显著且持续降低相关(18.5±1.9对36.5±5.4%),且未使其他灌注指标恶化。
在该脓毒症模型中,大量的LR或少量的HS可带来相似的短暂血流动力学益处。然而,单次推注HS确实可促使全身和肠系膜氧摄取持续降低,这表明高渗盐溶液可作为脓毒症患者液体复苏期间的有益干预措施。